Back to search

Article

Early minimal residual disease eradication in light chain amyloidosis generates deeper and faster cardiac response

2023-12-11

Abstract excerpt

<title>Abstract</title> <p>Minimal residual disease (MRD) is of growing interest in light chain (AL) amyloidosis and is associated with higher rates of cardiac response. A new graded cardiac response criteria has been proposed for better assessment of cardiac improvement. We evaluated MRD status in 63 patients with cardiac AL amyloidosis using next generation flow cytometry within four cycles after treatment init...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7d840fef-0533-50c3-8828-df8d4aebcc2b
DOI
10.21203/rs.3.rs-3710783/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Early minimal residual disease eradication in light chain amyloidosis generates deeper and faster cardiac responseDOI 10.21203/rs.3.rs-3710783/v1
Detection of minimal residual disease by next generation sequencing in AL amyloidosisSemantic proximity
Single-Cell Analysis Reveals Inflammatory–Immunosuppressive Niches in Daratumumab-Resistant Primary AL AmyloidosisSemantic proximity
Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains.Semantic proximity
Divergent Clinical Phenotypes, Organ Involvement, and Survival in AL Amyloidosis and Light Chain Deposition Disease: Insights From a Large Single-Center CohortSemantic proximity
Performance of a novel 8-color flow cytometry panel in the detection of minimal residual disease assessment of chronic lymphocytic leukemiaSemantic proximity
Emerging Pharmacological Strategies for Cardiac Amyloidosis: A Qualitative Analysis of Interventional Clinical Trials Registered on ClinicalTrials.govSemantic proximity
Biomarkers in AL AmyloidosisSemantic proximity
Echocardiographic phenotype for refined risk stratification and treatment selection in light chain amyloidosis with heart failure.Semantic proximity
An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 studySemantic proximity
Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patientsSemantic proximity
The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.Semantic proximity
AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survivalSemantic proximity
Select a neighboring publication to make it the new centre.